JENNISON ASSOCIATES LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 104 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$25,241,000
-17.7%
3,100,864
-18.4%
0.02%
-26.5%
Q4 2018$30,657,000
+4.4%
3,798,853
-1.3%
0.03%
+25.9%
Q3 2018$29,376,000
+47.7%
3,850,003
+10.9%
0.03%
+42.1%
Q2 2018$19,891,000
+19.0%
3,471,438
-0.9%
0.02%
+11.8%
Q1 2018$16,717,000
+10.5%
3,504,595
+13.7%
0.02%
+13.3%
Q4 2017$15,134,000
-6.1%
3,082,235
+0.2%
0.02%
-11.8%
Q3 2017$16,121,000
+39.3%
3,076,461
+47.8%
0.02%
+41.7%
Q2 2017$11,569,000
-25.3%
2,080,818
+12.8%
0.01%
-29.4%
Q1 2017$15,495,000
+80.6%
1,844,636
+36.1%
0.02%
+70.0%
Q4 2016$8,578,000
+44.0%
1,355,100
+0.3%
0.01%
+66.7%
Q3 2016$5,959,000
+54.7%
1,351,330
-0.4%
0.01%
+50.0%
Q2 2016$3,852,000
+0.3%
1,356,302
-0.1%
0.00%0.0%
Q1 2016$3,842,000
-72.4%
1,357,604
+0.7%
0.00%
-71.4%
Q4 2015$13,917,000
-7.8%
1,348,563
+1.8%
0.01%
-6.7%
Q3 2015$15,100,000
-23.2%
1,324,549
+0.5%
0.02%
-16.7%
Q2 2015$19,674,000
+123.9%
1,317,717
+35.4%
0.02%
+125.0%
Q1 2015$8,787,000
+179.5%
973,099
+202.7%
0.01%
+166.7%
Q3 2014$3,144,000
-23.2%
321,422
+0.1%
0.00%
-25.0%
Q2 2014$4,092,000
+7.9%
320,942
-10.5%
0.00%0.0%
Q1 2014$3,794,000
+39.7%
358,557
+0.3%
0.00%
+33.3%
Q4 2013$2,716,000
-17.1%
357,352
-20.6%
0.00%0.0%
Q3 2013$3,276,000450,0000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders